Omalizumab 80,797 16.58 48,537 Table S6 Full cost-effectiveness results for overall and subgroup populations under the list price Mean Mean ICER Population Intervention costs QALYs (£/QALY) (£) Adults and adolescents (≥ 12 years of age) age at model entry: 43 years – Overall Standard 33,218 13.66 patient care population Omalizumab 72,938 14.13 83,822 Children (6-11 years of age) age at – model entry: 9 years
Omalizumab 80,797 16.58 48,537 Table S6 Full cost-effectiveness results for overall and subgroup populations under the list price Population Intervention Mean costs (£) Mean QALYs ICER (£/QALY) Overall patient population Adults and adolescents (≥ 12 years of age) – age at model entry: 43 years Standard care 33,218 13.66 Omalizumab 72,938 14.13 83,822 Children (6-11 years of age) – age at model entry: 9 years
1-s2.0-S1098301514019330-mmc1.docx